# Riparian Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/riparian-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.riparianpharma.com
- Total disclosed funding: $3M
- Latest round: Series A (Oct 12, 2018)
- Investors on record: 3

## About

Founded in 2012 and based in Massachusetts, US, Riparian Pharmaceuticals, Inc. is a biotechnology company that researches and develops novel therapies using models of pathophysiology, to treat vascular diseases. The company cooperates with Brigham & Women’s Hospital, and the Biotech Community. Mr. Will Adams is the CEO and founder of the company.

The company provides vascular health therapeutics for vascular diseases.

## Funding rounds

- Series A, Oct 12, 2018, $3M — JMCR Family Office, Viva Ventures Biotech, Viva BioInnovator

## Investors

- JMCR Family Office — Series A
- Viva Ventures Biotech (https://capitalatlas.ai/funds/viva-ventures-biotech) — Series A
- Viva BioInnovator (https://capitalatlas.ai/funds/viva-bioinnovator) — Series A